RE:Glioblastoma. The time is now.When will shareholders get an update on these exciting initiatives from 2017:
Discovery of Super PDCs
Rutherin IV Administration
Theralase Anti-Cancer Vaccine
Preclinical Research Updates
Medical Advisory Appointments
Drug Manufacturing of Vaccine update
A great deal of promise here. We got to start other cancer trials.